← CellScience workspace
Rendered from briefs/nailscience/truth-gate.md

Truth Gate — NailScience (NS-01, 2-Step Nail Restoration Kit)

## ⏳ OPEN — David's verdicts on the 53 claims below are asked on the Launch Center lane nailscience (ask ns-truth-gate, posted 2026-10-29). Until he answers, every claim is PROVISIONAL: the angle bank cites them as research claims on an open gate, and no new customer-facing line rests on a ⚠ claim as written.

Rule (the house gate): anything in the FALSE list may not appear in brand identity, PDP copy, ads, email or creative briefs — in any paraphrase. TRUE claims are the factual foundation; final wording still passes the compliance officer (CL-00).

Sources: the April copy brief (07, Mode A — David 2026-10-14: no deep-research re-run), the live PDP, the two live prelanders (NS-P2 ranking · NS-P3 Dr. Franks), BRAND.md §1 (formula CLOSED 2026-10-14: what is on the PDP is what is in the pens), §3 (Ladder A), §5 (the proof lines to verify). Raw claims: truth-gate-claims.json.

Order of truth downstream (copy-laws §0): this gate → the live PDP (voice) → the copy brief → the angle bank's evidence → the swipe.

Problems

idClaim (⚠ = Claude's check)Verdict
p1About 1 in 10 adults has toenail fungus (onychomycosis), and the share rises sharply with age — roughly half of people over 70 (the PDP's line). ⚠ Prevalence figures range 2–14% in the general population and 20–50% in the elderly across studies; 'about 1 in 10, far more after 70' is the safe shape.—
p274% of people with nail fungus report embarrassment; women report severe embarrassment about twice as often as men (44% vs 26%). ⚠ The 74% is Drake et al. 1998 (a 258-patient quality-of-life survey); cite as 'a published patient survey', never as our customers.—
p3She hides her feet: no sandals, pools, beaches, pedicures or barefoot moments with a partner; summer is planned around closed-toe shoes (07 §2 'the compulsion to hide').—
p4The 'nothing works' exhaustion: creams, pens, vinegar soaks, tea tree oil, Vicks — a little improvement, then relapse; every new product is another risk of wasted money and hope; trust in the whole aisle is gone (07 §2, the #1 objection in §24).—
p5Fear of spread: to the other nails, and to family through shared showers and towels; thick nails catch on socks and press inside shoes (07 §2).—
p6Progress is invisible for months, which is why people quit; an early visible milestone (softer, thinner nail; a clear band at the base) is what keeps them on the product (07 §6, §24 objection 3).—
p7Oral antifungals (terbinafine / itraconazole) cure 70–90% but need liver-function blood tests and carry taste or smell loss, mood effects and rare liver injury; this market refuses them for what doctors call a cosmetic problem (07 §5). ⚠ Liver injury on terbinafine is rare (~1 in 50,000–120,000 courses) and taste disturbance ~3%: 'rare but documented', never 'liver failure' as the expected outcome.—
p8Prescription lacquers (Jublia / Penlac / Kerydin) are FDA-approved but Jublia can cost up to about $1,000 a bottle without insurance, insurers often deny it as cosmetic, and 48-week courses drive dropouts (07 §5). ⚠ List price ≈ $700–$1,000 for 4–8 ml: 'up to about $1,000'.—
p9A toenail takes 9–18 months to grow out completely, so a 'clear in 21 days' promise is biologically impossible (07 §5–6, the PDP: 'no brand can cheat biology').—

Rivals (facts only, attributed — CL-13: never a named rival as the target of a headline)

idClaim (⚠ = Claude's check)Verdict
c1Generic OTC antifungal creams (clotrimazole, terbinafine cream) are labeled for athlete's foot on the skin around the nail, not for the nail plate, which they cannot penetrate (07 §5).—
c2Antifungal pens carry 25% undecylenic acid — the right active at the top OTC strength — painted onto a thick, unprepared nail; many carry a label disclaimer that the product is not effective on the nail itself (07 §5, the NS-P2 ranking's #3).—
c3Crystal Flush's topical active is tolnaftate 1%, which the FDA OTC monograph lists for athlete's foot, jock itch and ringworm — not nails; buyers found the disclaimer after paying $115–140, and Truth-in-Advertising complaints + BBB investigations followed (07 §5). ⚠ Named rival: facts attributed to public records only.—
c4Kerassentials' directions require four applications a day, which its video sales letters and landing pages did not disclose; refund disputes and BBB complaints followed (07 §5). ⚠ Named rival: attribute.—
c5Kerasal uses the urea softening step but has no antifungal: the nail looks better, then the fungus comes back ('gets you halfway there, then stops' — NS-P2 #2). Kerasal calls itself the #1 dermatologist-recommended nail-renewal brand. ⚠ That '#1' is Kerasal's own survey claim — attribute it to them.—
c6Home remedies (Vicks, vinegar, tea tree, Listerine soaks) have active concentrations far too low, demand 30-minute daily soaks, and in the small studies that exist about 20–30% improve over 12+ months (07 §5).—
c7The three failure patterns across every rival: promising 21–30 days, skipping the softening step, hiding the 'not for nails' disclaimer (07 §5).—
c8A September 2025 FDA warning letter to Jublia's maker for implying a rapid cure in advertising (07 §16). ⚠ UNVERIFIED by Claude — not in copy until the letter is on file.—

The noun and the cause

idClaim (⚠ = Claude's check)Verdict
x1THE NOUN — the Keratin Shield: the nail plate is dense, packed keratin built to keep liquids out; a topical antifungal sits on top while the fungus lives in the nail bed underneath. The failure was never the strength of the medicine, it was delivery (07 §6; the PDP: 'like rubbing antibiotics on a cast'; NS-P2: 'your toenail is built like a shield').—
x2Dermatophytes in the nail form biofilms whose matrix makes them many times more resistant to antifungals than free-floating cells, with pumps that expel the drug (07 §6). ⚠ The brief's '2,000×' is a general biofilm figure (studies cite 10–1,000×): 'many times more resistant', no number.—
x3The two-step logic — soften and open the nail first, then treat underneath — is the sequence dermatology uses for chemical nail avulsion; this kit brings it home (07 §6, §16).—
x4Step 1 (urea + lactic acid + propylene glycol) softens and thins the nail plate, opens micro-channels and carries the active deeper: urea is a clinically validated keratolytic, lactic acid induces a porous microstructure in nail keratin, and propylene glycol raised an antifungal's solubility 12-fold and tissue accumulation 3-fold in a penetration-enhancer screening (07 §6, §8). ⚠ The 12× / 3× figures are one in-vitro screening with ciclopirox: 'in a lab study', never a nail-cure number.—
x5Step 2: 25% undecylenic acid, the maximum OTC antifungal concentration (FDA OTC monograph 21 CFR 333), plus tea tree, oregano, manuka and clove oils — broad-spectrum against dermatophytes (07 §6, §8; BRAND §1 formula CLOSED 2026-10-14).—
x6The Step 1 trio is the same keratolytic approach as Kerasal's renewal formula; this kit pairs it with a maximum-strength antifungal second step — the only at-home kit that does both (07 §9–10; the PDP: 'the only kit that opens the nail first, then treats underneath'). ⚠ 'Only' rests on the brief's survey of rivals: 'the only kit we know of' unless David wants the flat 'only'.—
x7'2-Step Penetration Technology™' is the PDP's name for the system. ⚠ ™ is a use claim, not a registration — the officer's question, not a copy constraint.—

Ingredient studies

idClaim (⚠ = Claude's check)Verdict
i120% urea + 2% butenafine cream for 16 weeks: 88% cure vs 0% placebo in a 60-patient double-blind trial of great-toenail onychomycosis, no relapses at one year (07 §8). ⚠ Syed et al. 1998 — the antifungal was butenafine, not undecylenic acid: evidence for the softening step, never this kit's cure rate.—
i2Texture-analyzer studies on bovine hoof membrane (the accepted in-vitro nail model): the higher the urea concentration, the less force it takes to puncture — nail softening confirmed (07 §8).—
i3A multicenter double-blind RCT, 493 patients, 24 weeks, on a urea / lactic acid / propylene glycol solution: 27.2% mycological cure vs 10.4% placebo (p = 0.0012), patient-reported improvement from week 2 (07 §8, §15). ⚠ This is the K101 / Emtrix (Nalox) trial, a different product with the same trio: cite as the trio's evidence, attributed.—
i4Faergemann & Swanbeck 1989: 21 of 23 patients improved on a urea / lactic acid / propylene glycol solution applied twice daily for up to six months (2 complete cures, 11 marked improvements) (07 §8).—
i5Undecylenic acid: clinical and mycological cure in 53% vs 7% of untreated controls in a 104-patient tinea pedis trial; decades of safety history including WWII military medicine (07 §8, §16). ⚠ 53% is athlete's foot (skin), not nails — never a nail-cure number.—
i6A tea tree + oregano + vitamin E nail oil: 78.5% complete cure at 12 months in a 20-patient study (University of Bologna), no side effects (07 §8, §15). ⚠ n = 20, open-label: 'a small clinical study'.—
i7Oregano oil lacquer completely inhibited dermatophyte growth in vitro (fungicidal); clove bud oil (eugenol) distorts and shrinks dermatophyte spores in vitro; East Cape manuka oil is up to 33× stronger than tea tree against certain bacteria (07 §8). ⚠ In-vitro and bacterial findings: never a patient-outcome number.—
i8A manuka oil spray, 12-week post-marketing study (NL / BE / UK): Onychomycosis Severity Index improved 26.8%, 67% significantly improved, 99% reported no discomfort (07 §8, §15). ⚠ Post-marketing, no placebo arm.—

Benefits and timelines (what we promise)

idClaim (⚠ = Claude's check)Verdict
b1Visible change within weeks: softer, thinner, less discolored nail as Step 1 clears damaged nail material — the PDP's 'see the yellow start fading in 2–4 weeks' (07 §6, §9; PDP).—
b2A band of clear new nail at the base is the first proof it is working — the PDP's 'new clear growth shows at the base by week 6–8' (07 §6, §23; PDP).—
b3Full clearance takes months because the nail has to grow out (9–18 months for a toenail) — and the brand says so; the honest timeline is a trust signal (07 §24 objection 3; PDP 'no brand can cheat biology').—
b4No pills, no blood tests, no liver monitoring, no drug interactions: a topical system, nothing reaches the bloodstream (07 §9, §24 objection 5).—
b5Sixty seconds, twice a day (the PDP's routine); dries fast, doesn't stain (a PDP review line).—
b6'Works when creams, polishes and pens failed — because it opens the nail first' (the PDP's lead benefit; 07 §9).—
b7Stop worrying about spreading it to other nails, your partner or your family (07 §9). ⚠ A contagion promise: 'treats the nail; the reinfection checklist is yours' is the safe shape.—
b8Positioning: cosmetic nail restoration, 'not a cure' (07 header, §14) — while the PDP says 'kills the fungus underneath' and 'the fungal colony'. ⚠ The two conflict: David picks the register (the officer rules on the words).—

Proof and persons on the live pages

idClaim (⚠ = Claude's check)Verdict
s1PDP: '★ 4.9 · 200,000+ verified customers'. ⚠ The May copy said '40,000+' (BRAND §5); neither matches the store's order history — David's call.—
s2PDP: '658 clinicians recommend NailScience'. ⚠ No source on file.—
s3PDP 'As featured in': Bustle, BAZAAR, FLAUNT, marie claire, Mashable, OK! — the prelanders say Forbes, The New York Times, CNN, USA TODAY, healthline, Women's Health. ⚠ Two different lists, no placements on file (the house rule: fictional call-letters, never real mastheads without a placement).—
s4NS-P3: 'Excellent · based on 3,214 reviews · Trustpilot'. ⚠ No Trustpilot profile on file (BRAND §5 'verify at the Truth Gate').—
s5The formulator persona differs by page: 'Dr. Miriam Patel, DPM, board-certified podiatrist, 14 years watching patients / 18 years in practice' (PDP) · 'Dr. Jamie Franks, podiatrist, 15 years, New York' (NS-P3) · 'Dr. Diana Hollis, Pharm.D., 14 years' (NS-P2). ⚠ Three fictional doctors across one funnel; the house line on fabricated records is David's — at minimum one persona per funnel.—
s6PDP: before/after photos and customer videos — 'real customers, same lighting, same camera, 90 days apart, unedited'. ⚠ Provenance of the April assets is not on file.—
s7NS-P2: 'The one that made women cry in the comments'. ⚠ The account's ads carry no public comments (dynamic creative) — no comments on file.—
s8Undecylenic acid was used by the U.S. Army in WWII against soldiers' foot infections (NS-P3, 07 §8) — TRUE in the literature (military tinea pedis use).—

Offer

idClaim (⚠ = Claude's check)Verdict
o1Ladder A (BRAND §3, locked 2026-10-14): $29.99 a kit · $59.98 for 3 · $89.97 for 5 · monthly $24.99 on 29next. ⚠ The PDP today shows $24.99 / $19.99 / $17.99 per kit ('Save $25 / $90 / $160') — verify which ladder is live before any price goes in copy.—
o230-Day Money-Back Guarantee, everywhere (the house law, David 2026-10-14) — the brief's 60–90-day suggestion is overruled.—
o3Try before you buy: one kit ships for $6.99, $24.99 on day 14, a fresh kit every 30 days, cancel any time with one click (the PDP trial row, 29next campaign 1494).—
o4The PDP banner: 'BLACK FRIDAY · DISCOUNT: SECRET50 · ENDS IN <timer>'; NS-P2: 'Try NailScience Today for 50% OFF'. ⚠ A code in copy must be real in Shopify with a real expiry (no fake scarcity).—
o5Free US shipping, ships today; 3 pens = one month (BRAND §1).—

✅ TRUE — the foundation

_Filled from David's verdicts (ask ns-truth-gate)._

🚫 FALSE — banned in any paraphrase

_Filled from David's verdicts._

💬 FEEDBACK

_David's notes → the fix._